Recharge Capital closed the first tranche of its $200 million women's health care fund, with plans to invest in fertility providers in emerging markets, Lorin Gu, founding partner at Recharge, tells Axios.
Why it matters: Recharge will invest in regions like Southeast Asia, which has become a fertility care destination for people in China — a country that restricts genetic testing and egg freezing for single women.
